Overactive, aggressive, disruptive and agitated behavior associated with the use of psychotropic medications in schizophrenia

[1]  L. Mehlum,et al.  Use of Benzodiazepines and Antipsychotic Drugs Are Inversely Associated With Acute Readmission Risk in Schizophrenia , 2021, Journal of clinical psychopharmacology.

[2]  L. Mehlum,et al.  Mortality and non-use of antipsychotic drugs after acute admission in schizophrenia: A prospective total-cohort study , 2021, Schizophrenia Research.

[3]  P. Lichtenstein,et al.  Associations between individual antipsychotics and the risk of arrests and convictions of violent and other crime: a nationwide within-individual study of 74 925 persons , 2021, Psychological Medicine.

[4]  P. Lichtenstein,et al.  Violence and mental disorders: a structured review of associations by individual diagnoses, risk factors, and risk assessment. , 2020, The lancet. Psychiatry.

[5]  G. Remington,et al.  Adherence to clozapine vs. other antipsychotics in schizophrenia , 2020, Acta psychiatrica Scandinavica.

[6]  T. Schneider-Axmann,et al.  Clozapine Combination and Augmentation Strategies in Patients With Schizophrenia -Recommendations From an International Expert Survey Among the Treatment Response and Resistance in Psychosis (TRRIP) Working Group. , 2020, Schizophrenia bulletin.

[7]  A. Tanskanen,et al.  Use of antidepressants and mood stabilizers in persons with first-episode schizophrenia , 2020, European Journal of Clinical Pharmacology.

[8]  L. Baandrup.  Polypharmacy in schizophrenia. , 2020, Basic & clinical pharmacology & toxicology.

[9]  S. Uysal.  ICD-10-CM Diagnosis Coding for Neuropsychological Assessment. , 2018, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

[10]  F. Clay,et al.  Benzodiazepines for Psychosis-Induced Aggression or Agitation , 2018, Schizophrenia bulletin.

[11]  Yuxiang Yan,et al.  Epidemiology of schizophrenia and risk factors of schizophrenia-associated aggression from 2011 to 2015 , 2018, The Journal of international medical research.

[12]  P. Masand,et al.  Biological treatment of acute agitation or aggression with schizophrenia or bipolar disorder in the inpatient setting. , 2017, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.

[13]  S. Leucht,et al.  Valproate for schizophrenia. , 2016, The Cochrane database of systematic reviews.

[14]  G. Vaiva,et al.  Lithium and suicide prevention in bipolar disorder. , 2016, L'Encephale.

[15]  P. Gøtzsche,et al.  Suicidality and aggression during antidepressant treatment: systematic review and meta-analyses based on clinical study reports , 2016, British Medical Journal.

[16]  J. Lohr,et al.  The clinical challenges of akathisia , 2015, CNS Spectrums.

[17]  B. Aouizerate,et al.  Medication and aggressiveness in real-world schizophrenia. Results from the FACE-SZ dataset , 2015, European Psychiatry.

[18]  C. Kuo,et al.  Risk factors for sudden cardiac death among patients with schizophrenia , 2015, Schizophrenia Research.

[19]  A. Tanskanen,et al.  Psychotropic drugs and homicide: A prospective cohort study from Finland , 2015, World psychiatry : official journal of the World Psychiatric Association.

[20]  P. Lichtenstein,et al.  Antipsychotics, mood stabilisers, and risk of violent crime , 2014, The Lancet.

[21]  H. Jørgensen,et al.  Time to discontinuation of antipsychotic drugs in a schizophrenia cohort: influence of current treatment strategies , 2014, Therapeutic advances in psychopharmacology.

[22]  J. Volavka.  Violence in schizophrenia and bipolar disorder. , 2013, Psychiatria Danubina.

[23]  T. Stroup,et al.  Polypharmacy for schizophrenia , 2013, Current opinion in psychiatry.

[24]  M. Picchioni,et al.  A systematic review of the evidence of clozapine's anti-aggressive effects. , 2012, The international journal of neuropsychopharmacology.

[25]  D. Healy,et al.  In response to “Antidepressants and lethal violence in the Netherlands” by D. Healy and T. Dehue , 2012, Psychopharmacology.

[26]  M. Liem,et al.  Antidepressants and lethal violence in the Netherlands 1994–2008 , 2012, Psychopharmacology.

[27]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[28]  M. Serper.  Aggression in schizophrenia. , 2011, Schizophrenia bulletin.

[29]  E. Torrey.  Stigma and violence: isn't it time to connect the dots? , 2011, Schizophrenia bulletin.

[30]  C. Furberg,et al.  Prescription Drugs Associated with Reports of Violence Towards Others , 2010, PloS one.

[31]  Hannah F Jones,et al.  Antiepileptics for aggression and associated impulsivity. , 2010, The Cochrane database of systematic reviews.

[32]  J. Geddes,et al.  Schizophrenia and Violence: Systematic Review and Meta-Analysis , 2009, PLoS medicine.

[33]  M. Pompili,et al.  Completed suicide in schizophrenia: Evidence from a case-control study , 2009, Psychiatry Research.

[34]  J. Volavka,et al.  Heterogeneity of violence in schizophrenia and implications for long‐term treatment , 2008, International journal of clinical practice.

[35]  A. McGirr,et al.  What is specific to suicide in schizophrenia disorder? Demographic, clinical and behavioural dimensions , 2008, Schizophrenia Research.

[36]  C. Mullins,et al.  Risk of discontinuation of atypical antipsychotic agents in the treatment of schizophrenia , 2008, Schizophrenia Research.

[37]  J. Kane,et al.  Methodological issues in current antipsychotic drug trials. , 2007, Schizophrenia bulletin.

[38]  S. Leucht,et al.  Epidemiology, clinical consequences, and psychosocial treatment of nonadherence in schizophrenia. , 2006, The Journal of clinical psychiatry.

[39]  M. Walsh,et al.  Selective serotonin reuptake inhibitors and violence: a review of the available evidence , 2001, Acta psychiatrica Scandinavica.

[40]  P. Grof,et al.  Lithium and suicide prevention , 1999, British Journal of Psychiatry.

[41]  J K Wing,et al.  Health of the Nation Outcome Scales (HoNOS) , 1998, British Journal of Psychiatry.

[42]  E. D. Myers.  ‘Biological’ Treatment , 1989, British Journal of Psychiatry.

[43]  A. Włodarczyk,et al.  Benzodiazepines in combination with antipsychotic drugs for schizophrenia: GABA-ergic targeted therapy. , 2017, Psychiatria Danubina.

[44]  E. Gambrill.  Evidence-based practice in the field of substance abuse: a book of readings. , 2010 .

[45]  P. McHugh,et al.  Suicide in patients hospitalized for schizophrenia: 1913-1940. , 1999, The Journal of nervous and mental disease.

[46]  R. Drake,et al.  Assessing substance use disorder in persons with severe mental illness. , 1996, New directions for mental health services.

[47]  D. Marchant,et al.  Risk factors. , 1994, Obstetrics and gynecology clinics of North America.